Skip to content

Relationship between serum adiponectin and intima media thickness of dorsalis pedis artery in type 2 diabetes with macroangiopathy

Relationship between serum adiponectin and intima media thickness of dorsalis pedis artery in type 2 diabetes with macroangiopathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17011731
Enrollment
Unknown
Registered
2017-06-21
Start date
2017-06-22
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

T2DM subjects with macroangiopathy:Nil
T2DM subjects without macroangiopathy:Nil
Normal Contro:Nil

Sponsors

Affiliated Longyan First Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria for the subjects with T2DM using World Health Organization criteria(1999) and/or was being treated with insulin or oral hypoglycemic agents.Inclusion criteria for the diabetic macroangiopathy applied were at least one of the following: diagnosis of coronary heart disease, cerebral infarction and peripheral vascular ischemic disease by the medical specialist ever accoding to the clinical symptoms, signs and auxiliary examination definitely, cerebral infarction lesions were found by brain magnetic resonance imaging scan, atherosclerotic plaques of peripheral blood vessels (bilateral carotid artery or lower extremity artery, etc)were found by color doppler ultrasound examination, ischemic myocardial injury was found by ECG, dynamic electrocardiogram, echocardiography, percutaneous coronary angiography.

Exclusion criteria

Exclusion criteria: Exclusion criteria applied were as follows: acute infectious disease such as cold or diarrhea, uncontrolled hypertension, non homeostasis such as diabetic ketoacidosis, hyperosmolar syndrome or hypoglycemia, severe dyslipidemia, clear microvascular lesions such as diabetic nephropathy or retinopathy, autoimmune disease or maligant tumor.

Design outcomes

Primary

MeasureTime frame
Adiponectin;intima media thickness of dorsalis pedis artery (D-IMT);

Secondary

MeasureTime frame
body mass index;systolic blood pressure;diastolic blood pressure;fasting plasma glucose;postprandial 2 hours blood glucose;glycosylated hemoglobin;total cholesterol;triglyceride;high density lipoprotein cholesterol;low density lipoprotein cholesterol;uric acid;Fibrinogen;fasting insulin;homeostasis model assessment 2 of insulin resistance(HOMA2);high sensitivity C reactive protein;Diabetic duration;Age;gender;Cigarette smoking;Alcohol drinking;

Countries

China

Contacts

Public ContactMei Tu

Affiliated Longyan First Hospital of Fujian Medical University

380468693@qq.com+86 15960332856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026